Neo Marketing: (Correction/Numerical Data Correction) Partial Corrections to the “Financial Results Report for the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)”

JPX02:00 ET · Announcements

Neo Marketing - For the fiscal year ending September 2024, although there will be a decrease in revenue, focus will be on activities aimed at expanding the medium- to long-term order system and service provision system.

Neo Marketing <4196> announced its consolidated financial results for the fiscal year ending September 2024 on the 13th. The revenue decreased by 7.8% compared to the previous year to 2.098 billion yen, operating profit decreased by 95.0% to 0.015 billion yen, ordinary profit decreased by 95.5% to 0.014 billion yen, and net income attributable to parent company shareholders decreased by 25.7% to 0.147 billion yen. During the period, efforts were focused on recruitment and development activities in line with the mid-term management plan. Initiatives to strengthen organizational and sales capabilities included the position of marketing consultant.

Fisco JapanNov 14 04:57 ET

Neo Marketing: Financial results presentation materials for the fiscal year ending 2024/9

JPXNov 13 02:00 ET · Announcements

Neo Marketing: Summary of Financial Results for the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)

JPXNov 13 02:00 ET · Announcements

Part 2 of the previous day's moving stocks include M&A SOKO Holdings, Sakura Internet, Big Camera, etc.

Stock name (code) 20-day closing price ⇒ Previous day comparison Kitagawa Seiki <6327> 723-48. June 2015 operating profit is expected to decrease by 38%. MonotaRO <3064> 2,458.5-7. Sell off profits against the recent rise continues. Neo Marketing <4196> 1107 +20 Release a beta version of the new interview service "Chat AI Research DEMO!" that takes advantage of the latest AI technology. M&A Consulting Holdings <9552> 2785

Fisco JapanAug 20 18:32 ET

Stocks that moved the previous day, part 1: 7&iHD, Shionogi & Co., Ltd., Double A, etc.

Stock name <code>19 closing price ⇒ comparison with the previous dayAsuka Pharmaceutical HD <4886> 2,309 + 21 Obtained approval for manufacturing and selling oral contraceptive drospirenone in South Korea. In the afternoon, the increase narrowed. 7&iHD <3382> 2,161 + 400 Acquired proposal reported from Canada's largest convenience store chain, Alimentation Couche-Tard. Renascience <4889> 353 + 14 Clinical performance tests of AI to predict insulin dosage for diabetes patients have started. Economic <3802>

Fisco JapanAug 19 18:15 ET